Taro Pharmaceutical Indus...

NYSE: TARO · Real-Time Price · USD
42.98
0.01 (0.02%)
At close: Jun 21, 2024, 9:59 PM

Taro Pharmaceutical Industries Ratios and Metrics

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
PE Ratio
29.47 35.92 27.95 -7.03
PEG Ratio
0.27 -0.64 -0.24 0.03
PS Ratio
2.52 1.60 2.90 5.13
PB Ratio
0.89 0.53 0.95 1.65
P/FCF Ratio
20.30 65.75 -9.54 98.44
P/OCF Ratio
11.99 28.79 -10.26 61.57
OCF/S Ratio
0.21 0.06 -0.28 0.08
Debt / Equity Ratio
n/a 0.00 0.00 0.00
Quick Ratio
3.04 2.88 2.61 1.91
Current Ratio
3.61 3.47 3.10 2.17
Asset Turnover
0.29 0.27 0.26 0.23
Interest Coverage
n/a 14.14 111.53 516.83
Return on Equity
0.03 0.01 0.03 -0.24
Return on Assets
0.02 0.01 0.03 -0.17
Return on Invested Capital
0.01 0.01 0.08 0.42
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.48 0.47 0.52 0.54
Net Profit Margin
0.09 0.04 0.10 -0.73
Pretax Profit Margin
0.13 0.07 0.14 -0.71
Operating Profit Margin
0.03 0.03 0.33 1.28
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
0.06 0.09 0.29 -0.75